Deep brain stimulation for refractory epilepsy.

Area of Science:

• Neurology
• Neurosurgery
• Epileptology

Background:

• Medically refractory epilepsy (RE) presents a significant challenge for patients unresponsive to conventional treatments.
• Deep brain stimulation (DBS) is an emerging therapeutic option for individuals with RE who are ineligible for or have not benefited from surgical resection.
• Established stereotactic targets for DBS in epilepsy include the anterior thalamic nucleus, subthalamic nucleus, and hippocampus.

Purpose of the Study:

• To review the efficacy and application of Deep Brain Stimulation (DBS) for managing medically refractory epilepsy (RE).
• To highlight the potential benefits of DBS for patients with epilepsy who have exhausted other treatment avenues.

Main Methods:

• Literature review of studies investigating DBS for refractory epilepsy.
• Analysis of common stereotactic targets utilized in DBS procedures for epilepsy.
• Evaluation of the effectiveness and side effect profile of DBS in adult and adolescent epilepsy populations.

Main Results:

• Deep brain stimulation (DBS) demonstrates efficacy in controlling seizures for various epilepsy types in adults and adolescents.
• Commonly targeted brain regions include the anterior thalamic nucleus, subthalamic nucleus, central-medial thalamic nucleus, hippocampus, amygdala, and cerebellum.
• Potential side effects are associated with electrode implantation and the stimulation parameters.

Conclusions:

• Deep brain stimulation (DBS) is a promising treatment for medically refractory epilepsy (RE).
• Growing research and interest suggest a future standardization of DBS protocols for RE management.
• Further investigation into optimal targeting and stimulation parameters may enhance DBS efficacy and safety.